Attar C. Eyal's Insider Trades & SAST Disclosures
Attar C. Eyal's most recent trade in Vor Biopharma Inc was a trade of 2,227 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Attar C. Eyal.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.42 per share. | 13 Feb 2025 | 2,227 | 126,625 | - | 1.4 | 3,162 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.37 per share. | 10 Feb 2025 | 2,554 | 128,852 | - | 1.4 | 3,499 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 06 Feb 2025 | 1,180 | 131,406 | - | 1.5 | 1,770 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 364,000 | 364,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 364,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 315,000 | 315,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2025 | 109,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 109,000 | 109,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 52,500 | 132,586 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 03 Feb 2025 | 1,353 | 80,086 | - | 1.3 | 1,813 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 27 Dec 2024 | 10,334 | 81,439 | - | 1.3 | 12,918 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 06 Nov 2024 | 999 | 91,773 | - | 0.9 | 859 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 01 Nov 2024 | 1,146 | 92,772 | - | 0.8 | 917 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 06 Aug 2024 | 999 | 93,918 | - | 0.9 | 869 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 01 Aug 2024 | 1,146 | 94,917 | - | 0.9 | 1,077 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 03 Jun 2024 | 14,645 | 96,063 | - | 1.4 | 20,357 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.75 per share. | 06 May 2024 | 999 | 110,708 | - | 1.7 | 1,748 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 01 May 2024 | 1,146 | 111,707 | - | 1.8 | 2,028 | Common Stock |
| Vor Biopharma Inc | Attar C. Eyal | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.32 per share. | 06 Feb 2024 | 1,180 | 112,853 | - | 2.3 | 2,738 | Common Stock |
| Vor Biopharma Inc | C. Eyal Attar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal Attar C. | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 62,500 | 114,033 | - | 0 | Common Stock | |
| Vor Biopharma Inc | Eyal C. Attar | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. | 07 Aug 2023 | 999 | 52,532 | - | 2.7 | 2,667 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 08 May 2023 | 969 | 53,531 | - | 4.1 | 4,012 | Common Stock |
| Vor Biopharma Inc | Eyal C. Attar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 109,000 | 109,000 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Eyal C. Attar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 54,500 | 54,500 | - | 0 | Common Stock | |
| Aprea Therapeutics Inc | Eyal C. Attar | Director, SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.81 per share. | 03 Jun 2022 | 32,667 | 57,233 (0%) | 0% | 0.8 | 26,297 | Common Stock |
| Aprea Therapeutics Inc | Eyal C. Attar | Director, SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 185,900 | 185,900 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Eyal C. Attar | Director, SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 42,900 | 89,900 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Eyal C. Attar | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.73 per share. | 28 Feb 2022 | 36,000 | 47,000 (0%) | 0% | 1.7 | 62,280 | Common Stock |
| Aprea Therapeutics Inc | Eyal C. , Attar | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 16 Sep 2021 | 15,968 | 83,000 (0%) | 0% | 4.7 | 74,730 | Common Stock |
| Aprea Therapeutics Inc | Eyal C. , Attar | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.98 per share. | 25 Aug 2021 | 9,032 | 98,968 (0%) | 0% | 4.0 | 35,947 | Common Stock |
| Aprea Therapeutics Inc | Eyal C. , Attar | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 143,000 | 143,000 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Eyal C. , Attar | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 75,000 | 108,000 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Eyal C. , Attar | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 33,000 | 33,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges